What is Orbital Atherectomy for Peripheral Artery Disease (PAD)?
Peripheral Artery Disease (PAD) is a prevalent circulatory condition characterized by the narrowing of arteries that supply blood to the limbs, most commonly the legs. This narrowing is primarily caused by atherosclerosis, a process involving the buildup of plaque—composed of fats, cholesterol, calcium, and other substances—on the inner walls of the arteries. As plaque accumulates, it hardens and restricts blood flow, leading to symptoms such as leg pain during walking (claudication), numbness, coldness in the lower leg or foot, and, in severe cases, non-healing sores or gangrene. Effective management of PAD is crucial to alleviate symptoms, improve quality of life, and prevent serious complications, including limb loss and cardiovascular events. Among the various interventional strategies available, atherectomy has emerged as a significant tool for plaque removal, with orbital atherectomy representing an advanced technique for addressing calcified lesions.
Understanding Atherectomy in PAD Management
Atherectomy is a minimally invasive endovascular procedure designed to remove atherosclerotic plaque from arteries, thereby restoring adequate blood flow. Unlike angioplasty, which compresses plaque against the arterial wall, atherectomy physically extracts or ablates the plaque. This approach is particularly beneficial in cases where plaque is heavily calcified, making it resistant to balloon angioplasty alone. Several types of atherectomy devices exist, each employing a distinct mechanism for plaque removal. These include excisional atherectomy (using a blade to cut plaque), laser ablation atherectomy (using a laser to vaporize plaque), rotational atherectomy (using tiny blades in a circular motion), and orbital atherectomy.
The Mechanism of Orbital Atherectomy
Orbital atherectomy (OA) is a specialized form of atherectomy that utilizes a high-speed, eccentrically mounted, diamond-coated crown to ablate calcified plaque. The device, such as the Diamondback 360 Peripheral Orbital Atherectomy System, operates by rotating at varying speeds, creating an orbital sanding effect that selectively removes hard, calcified plaque while minimizing damage to the elastic arterial wall [1] [2]. The crown's eccentric rotation allows it to treat vessels of different diameters by adjusting the speed, which in turn alters the orbit of the crown within the artery. At lower speeds, the crown maintains a smaller orbit, while at higher speeds, centrifugal force expands its orbit, enabling treatment of larger vessel lumens. This differential sanding mechanism is particularly advantageous for modifying severely calcified lesions, making them more compliant for subsequent balloon angioplasty and stent placement, if necessary [1].
Procedural Aspects of Orbital Atherectomy for PAD
The orbital atherectomy procedure typically involves the following steps: After administering local anesthesia and mild sedation, a healthcare provider inserts a catheter into an artery, usually in the groin or arm. The catheter is then guided to the site of the plaque buildup in the peripheral artery. The orbital atherectomy device, with its diamond-coated crown, is advanced through the catheter to the target lesion. The crown is then activated to rotate and ablate the calcified plaque into fine particles, which are typically small enough to be safely cleared by the bloodstream or filtered out [1] [2]. The procedure is performed under fluoroscopic guidance to ensure precise plaque removal. After atherectomy, the artery is often further dilated with a balloon (angioplasty) and, in some cases, a stent may be placed to maintain vessel patency. Post-procedure, patients are monitored for a few hours before discharge, with most able to resume normal activities within a few days [2].
Indications and Contraindications for OA in PAD
Orbital atherectomy is primarily indicated for patients with PAD who have severely calcified lesions that are difficult to treat with balloon angioplasty alone. It is particularly useful for lesions that are long, diffuse, or located in challenging anatomical areas. The goal is to improve vessel compliance and facilitate optimal stent deployment, thereby reducing the risk of restenosis and improving long-term outcomes [1].
However, OA is contraindicated in certain situations, including: inability to pass a guidewire across the lesion, presence of thrombus (blood clot) in the artery, lesions within a graft or stent, and in patients who are not candidates for percutaneous transluminal angioplasty or bypass surgery. Other considerations include very tortuous vessels, which may increase the risk of vessel damage, and specific patient conditions such as pregnancy or severe heart failure [1].
Risks, Complications, and Outcomes
While orbital atherectomy is generally considered safe and effective, potential risks and complications exist. These can include arterial dissection (a tear in the artery wall), perforation (a hole in the artery), slow or no-reflow phenomena (reduced blood flow after the procedure), and distal embolization (plaque particles traveling downstream and blocking smaller vessels) [1] [2]. Transient bradycardia (slow heart rate) has also been observed. However, clinical studies, such as the ORBIT II trial (primarily focused on coronary arteries but providing insights into atherectomy outcomes), have demonstrated favorable safety profiles and significant improvements in vessel patency and clinical outcomes following OA [1]. For PAD, atherectomy often relieves symptoms without major surgery, with a typical procedure lasting about two hours [2]. The long-term efficacy of OA in PAD patients, particularly in preventing re-interventions and improving limb salvage rates, continues to be a subject of ongoing research and clinical evaluation.
Conclusion
Orbital atherectomy represents a valuable and increasingly utilized treatment modality in the comprehensive management of Peripheral Artery Disease, especially for patients presenting with severely calcified arterial lesions. By effectively removing hardened plaque, OA facilitates successful revascularization, improves blood flow to the affected limbs, and contributes to better patient outcomes. As with any medical procedure, careful patient selection, thorough procedural planning, and skilled execution are paramount to maximizing benefits and minimizing risks. Continued advancements in atherectomy technologies and further clinical research will undoubtedly refine its application and enhance its role in the evolving landscape of PAD treatment.
References
[1] Shipman, J. N., & Agasthi, P. (2023). *Orbital Atherectomy*. StatPearls - NCBI Bookshelf. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK563144/ [2] Cleveland Clinic. (2022, October 19). *Atherectomy: Procedure Details & Purpose*. Retrieved from https://my.clevelandclinic.org/health/treatments/17310-pad-atherectomy